Health ❯Healthcare ❯Immunotherapy
mRNA-based Immunotherapy Neoantigen Vaccines Nivolumab
Demonstrating an absolute 10% survival gain, this CheckMate816 update is driving worldwide adoption of the combined preoperative regimen